'I feel like I'm drowning': thousands with cystic fibrosis wait to hear if 'life-saving' drug will be listed on PBS

27 January 2022 - Matt Dickinson was struggling to breathe when his mother rushed him to an Adelaide hospital earlier ...

Read more →

Australians deserve fast access to the latest medicines, vaccines and treatments

28 January 2022 - Medicines Australia recommends the Australian Government delivers a plan to shorten the time that patients wait ...

Read more →

Positive Early Access to Medicines Scheme (EAMS) scientific opinion awarded to GBT’s voxelotor for the treatment of haemolytic anaemia due to sickle cell disease

27 January 2022 - Global Blood Therapeutics today announced that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has awarded ...

Read more →

Former bowel cancer patient calls for NZ to fund drug she says saved her life

26 January 2022 - A woman with bowel cancer who was told she may have two years to live says ...

Read more →

PHARMAC confirms access criteria for COVID-19 treatments

26 January 2022 - PHARMAC has today confirmed the access criteria for two COVID-19 treatments – baricitinib and casirivimab with ...

Read more →

Breast cancer patients in Scotland are set to receive tumour blasting wonder drug that starts working in weeks - sparking hopes of a wider rollout for NHS patients across the rest of the UK

23 January 2022 - A breast cancer drug that can melt away tumours in weeks has been given the green ...

Read more →

People with chronic myeloid leukaemia granted early access to Novartis’ investigational treatment

24 January 2022 - The Medicine and Healthcare products Regulatory Agency grants positive scientific opinion on use of asciminib as 3rd-line ...

Read more →

Novavax COVID-19 vaccine to be available in coming weeks

24 January 2022 - Australians aged 18+ will now have access to a fourth COVID-19 vaccine, Nuvaxovid (Novavax) in coming weeks, ...

Read more →

Patients to receive new cancer drugs faster under Brexit rules shake-up

23 January 2022 - Seven medicines already approved as changes cut as much as a month off approval times. ...

Read more →

Australians with severe dermatitis to benefit from PBS listing

24 January 2022 - From 1 February 2022, Australians with severe atopic dermatitis will have access to a new treatment ...

Read more →

Thousands to benefit from decision to subsidise eczema treatment

23 January 2022 - Australians suffering from a severe form of eczema will save tens of thousands of dollars after a ...

Read more →

COVID-19: early access granted to Paxlovid as a curative treatment

21 January 2022 - In the context of very high circulation of SARS-CoV-2, the High Authority for Health (HAS) and the ...

Read more →

Patent thickets are thwarting U.S. availability of lower cost biosimilar medicines, study finds

18 January 2022 - Amid debate over competition in the pharmaceutical industry, a new analysis found just 6% of patents ...

Read more →

Keytruda reimbursement boosts MSD’s R&D of follow-up drug

17 January 2022 - The government’s recognition of MSD’s Keytruda (pembrolizumab) for reimbursement as the first-line therapy for lung cancer ...

Read more →

$421,000 cancer drug Kymriah becomes eligible for reimbursement

14 January 2022 - Novartis’ breakthrough cancer treatment Kymriah (ingredient: tisagenlecleucel), which costs over 500 million won (US$421,000), has become ...

Read more →